In summary, our results suggest that the ratio of peripheral blood CD56bright NK to CD56dim NK has the potential to identify the pSS patients and was associated with serum IgG levels and complement C3 and C4 consumption. The gene discussed is C4A; the disease is peeling skin syndrome.